tyrosyl-arginyl-phenylalanyl-lysinamide has been researched along with Neuralgia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shantanu, PA; Tiwari, V; Vaidya, S | 1 |
| Schiller, PW; Shimoyama, M; Shimoyama, N; Szeto, HH; Toyama, S | 1 |
2 other study(ies) available for tyrosyl-arginyl-phenylalanyl-lysinamide and Neuralgia
| Article | Year |
|---|---|
Attenuation of ongoing neuropathic pain by peripheral acting opioid involves activation of central dopaminergic neurocircuitry.
Topics: Analgesics, Opioid; Animals; Brain; Cell Line, Tumor; Computer Simulation; Disease Models, Animal; Dopamine; Dopaminergic Neurons; Humans; Male; MAP Kinase Signaling System; Neuralgia; Oligopeptides; Rats; Spinal Cord; Synaptic Transmission | 2021 |
Superior analgesic effect of H-Dmt-D-Arg-Phe-Lys-NH2 ([Dmt1]DALDA), a multifunctional opioid peptide, compared to morphine in a rat model of neuropathic pain.
Topics: Analgesics, Opioid; Animals; Male; Morphine; Neuralgia; Oligopeptides; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu | 2012 |